Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.

Obesity Clinical Trial

— OBIMPACOV  

Official title:

Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04910607
• Other study ID #: CHUBX 2020/38
• Status: Completed
• Start date: January 21, 2022
• Est. completion date: July 28, 2023

Study information

• Verified date: December 2023
• Source: University Hospital, Bordeaux
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The population suffering from obesity is particularly at risk during this pandemic period. The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or obese.

Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.

Description:

This is a prospective multicentre study. Participating patients will be recruited from the Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a questionnaire and take part in an interview (a varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).

The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 279
• Est. completion date: July 28, 2023
• Est. primary completion date: July 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients 18 years of age.

• Be registered in an active file of the 3 partner CSOs.

Exclusion Criteria:

• Patients under 18 years of age.

• Patients under protective measures or deprived of liberty:

• pregnant or breastfeeding woman,

• under guardianship,

• under guardianship,

• safeguard of justice,

• incarcerated.

Related Conditions & MeSH terms

• COVID-19
• Covid19
• Obesity

Intervention

Other:
• Questionnaire
Questionnaire with 4 axes: sociological, reflexive medical, prospective medical, transversal
• Interview
Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

Locations

Country	Name	City	State
France	CHU de Limoges	Limoges
France	Hôpital Haut-Lévêque	Pessac
France	CHU de Poitiers	Poitiers

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Bordeaux	Région Nouvelle Aquitaine

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analysed social and psychological impacts of containment	Thanks to sociology questionnaire based on the experience and paths of individuals (not a score).; The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.	9 months after inclusion day
Primary	Consequences of social distancing during the containment	Thanks to sociology questionnaire based on the experience and paths of individuals(not a score).; The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.	9 months after inclusion day